Overview
SCIENTIFIC SCORE
Moderately Effective
Based on 2 Researches
8.5
USERS' SCORE
Medium or Average
Based on 12 Reviews
6
Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving
%DV
MethylSulfonylMethane (MSM)
1,000 mg
†
Top Medical Research Studies
8
We dived into how adherence to acute migraine medications influences migraine severity and patient satisfaction. Over three months, participants diligently recorded their migraine experiences in daily diaries.
With 337 adults participating, the findings showed that those using migraine-specific medication (MSM), especially when pain was milder, reported the best outcomes. This included less daily disability and greater satisfaction with their medication.
Our results suggest that starting treatment with MSM may lead to a better quality of life for migraine sufferers.
With 337 adults participating, the findings showed that those using migraine-specific medication (MSM), especially when pain was milder, reported the best outcomes. This included less daily disability and greater satisfaction with their medication.
Our results suggest that starting treatment with MSM may lead to a better quality of life for migraine sufferers.
Read More
9
Erenumab reduces migraine medication use
We explored how erenumab impacts the use of acute headache medication, especially migraine-specific medications (MSM). The study analyzed data from two major clinical trials involving patients with episodic migraine (EM) and chronic migraine (CM). Participants received either erenumab or placebo over a set period, allowing us to compare medication usage accurately.
Our findings indicate that treatment with erenumab led to a significant decrease in the number of days patients used acute headache medications, particularly in those relying on MSM. This reduction was observed in both episodic and chronic migraine patients, suggesting that erenumab not only helps manage migraines but may also help mitigate the need for additional acute treatment.
Overall, these results highlight the potential benefits of erenumab in addressing not just the frequency of migraines but also reducing dependence on medications traditionally used for acute migraine relief.
Our findings indicate that treatment with erenumab led to a significant decrease in the number of days patients used acute headache medications, particularly in those relying on MSM. This reduction was observed in both episodic and chronic migraine patients, suggesting that erenumab not only helps manage migraines but may also help mitigate the need for additional acute treatment.
Overall, these results highlight the potential benefits of erenumab in addressing not just the frequency of migraines but also reducing dependence on medications traditionally used for acute migraine relief.
Read More
Most Useful Reviews
9
Headache relief
52 people found this helpful
Fibromyalgia has vanished! This MSM is high quality and absorbs quickly. My husband's asthma and plantar fasciitis improved. However, I recommend starting with one or two capsules a day with a meal, as it can detox your body, causing headaches if increased too quickly. Keep L. Arginine and L. Ornithine on hand for detox symptoms. My skin looks fabulous, aches are gone, and my immune system has improved. I truly believe in the miracle of MSM!
Read More
0
Headache issue
I tried this for its anti-inflammatory benefits but stopped due to headache side effects.
Read More
0
Headache experience
84 people found this helpful
After taking this, I experienced constant headache throughout the day. The product did not dissolve well in water, likely due to magnesium stearate, which could be contributing to my headache.
Read More
Medical Researches
SCIENTIFIC SCORE
Moderately Effective
Based on 2 Researches
8.5
- All Researches
9
Erenumab reduces migraine medication use
We explored how erenumab impacts the use of acute headache medication, especially migraine-specific medications (MSM). The study analyzed data from two major clinical trials involving patients with episodic migraine (EM) and chronic migraine (CM). Participants received either erenumab or placebo over a set period, allowing us to compare medication usage accurately.
Our findings indicate that treatment with erenumab led to a significant decrease in the number of days patients used acute headache medications, particularly in those relying on MSM. This reduction was observed in both episodic and chronic migraine patients, suggesting that erenumab not only helps manage migraines but may also help mitigate the need for additional acute treatment.
Overall, these results highlight the potential benefits of erenumab in addressing not just the frequency of migraines but also reducing dependence on medications traditionally used for acute migraine relief.
Our findings indicate that treatment with erenumab led to a significant decrease in the number of days patients used acute headache medications, particularly in those relying on MSM. This reduction was observed in both episodic and chronic migraine patients, suggesting that erenumab not only helps manage migraines but may also help mitigate the need for additional acute treatment.
Overall, these results highlight the potential benefits of erenumab in addressing not just the frequency of migraines but also reducing dependence on medications traditionally used for acute migraine relief.
Read More
8
We dived into how adherence to acute migraine medications influences migraine severity and patient satisfaction. Over three months, participants diligently recorded their migraine experiences in daily diaries.
With 337 adults participating, the findings showed that those using migraine-specific medication (MSM), especially when pain was milder, reported the best outcomes. This included less daily disability and greater satisfaction with their medication.
Our results suggest that starting treatment with MSM may lead to a better quality of life for migraine sufferers.
With 337 adults participating, the findings showed that those using migraine-specific medication (MSM), especially when pain was milder, reported the best outcomes. This included less daily disability and greater satisfaction with their medication.
Our results suggest that starting treatment with MSM may lead to a better quality of life for migraine sufferers.
Read More
User Reviews
USERS' SCORE
Medium or Average
Based on 12 Reviews
6
- All Reviews
- Positive Reviews
- Negative Reviews
9
Headache relief
52 people found this helpful
Fibromyalgia has vanished! This MSM is high quality and absorbs quickly. My husband's asthma and plantar fasciitis improved. However, I recommend starting with one or two capsules a day with a meal, as it can detox your body, causing headaches if increased too quickly. Keep L. Arginine and L. Ornithine on hand for detox symptoms. My skin looks fabulous, aches are gone, and my immune system has improved. I truly believe in the miracle of MSM!
Read More
0
Headache issue
I tried this for its anti-inflammatory benefits but stopped due to headache side effects.
Read More
0
Headache experience
84 people found this helpful
After taking this, I experienced constant headache throughout the day. The product did not dissolve well in water, likely due to magnesium stearate, which could be contributing to my headache.
Read More
6
Prevents headache triggers
20 people found this helpful
This fixed my leg, hand, and neck cramps after numerous doctors could not help. A friend recommended it, leading to no more cramps. If I become dehydrated after drinking, this helps hydrate my muscles, preventing tightness in my neck, which can lead to headaches and TMJ flare-ups.
Read More
7.5
Headache reduction
1 people found this helpful
MSM is a beneficial organic compound that improves joint health, skin, and immune support. It reduces muscle and joint pain, including headaches, making it effective for back pain and other symptoms.
Read More
Frequently Asked Questions
0
Headache experience
84 people found this helpful
After taking this, I experienced constant headache throughout the day. The product did not dissolve well in water, likely due to magnesium stearate, which could be contributing to my headache.
7.5
Headache eased
After injuring my knee while running, I found relief after taking this product, which alleviated my headache as well.
6
Headache concerns
1 people found this helpful
I purchased this for my bad knees, as it's popular for joint support. While it has many benefits, I've experienced headaches and increased intraocular pressure. I'm also taking a multivitamin with molybdenum to manage these side effects.
9
Headache relief
52 people found this helpful
Fibromyalgia has vanished! This MSM is high quality and absorbs quickly. My husband's asthma and plantar fasciitis improved. However, I recommend starting with one or two capsules a day with a meal, as it can detox your body, causing headaches if increased too quickly. Keep L. Arginine and L. Ornithine on hand for detox symptoms. My skin looks fabulous, aches are gone, and my immune system has improved. I truly believe in the miracle of MSM!
0
Headache issue
I tried this for its anti-inflammatory benefits but stopped due to headache side effects.
1
Headache trouble
While it benefits skin and joints and alleviates pain, I experience headaches as a side effect, preventing me from using it frequently.
2
Headache side effects
1 people found this helpful
I tried this as my usual brand was out of stock. The capsules are smaller and easier to swallow. Initially, I experienced a slight headache and stomach ache, but they diminished. However, after two weeks, I suffered skin issues, nightmares, headaches, and nausea, making it unsuitable for me.
9
Erenumab reduces migraine medication use
We explored how erenumab impacts the use of acute headache medication, especially migraine-specific medications (MSM). The study analyzed data from two major clinical trials involving patients with episodic migraine (EM) and chronic migraine (CM). Participants received either erenumab or placebo over a set period, allowing us to compare medication usage accurately.
Our findings indicate that treatment with erenumab led to a significant decrease in the number of days patients used acute headache medications, particularly in those relying on MSM. This reduction was observed in both episodic and chronic migraine patients, suggesting that erenumab not only helps manage migraines but may also help mitigate the need for additional acute treatment.
Overall, these results highlight the potential benefits of erenumab in addressing not just the frequency of migraines but also reducing dependence on medications traditionally used for acute migraine relief.
Our findings indicate that treatment with erenumab led to a significant decrease in the number of days patients used acute headache medications, particularly in those relying on MSM. This reduction was observed in both episodic and chronic migraine patients, suggesting that erenumab not only helps manage migraines but may also help mitigate the need for additional acute treatment.
Overall, these results highlight the potential benefits of erenumab in addressing not just the frequency of migraines but also reducing dependence on medications traditionally used for acute migraine relief.
8
We dived into how adherence to acute migraine medications influences migraine severity and patient satisfaction. Over three months, participants diligently recorded their migraine experiences in daily diaries.
With 337 adults participating, the findings showed that those using migraine-specific medication (MSM), especially when pain was milder, reported the best outcomes. This included less daily disability and greater satisfaction with their medication.
Our results suggest that starting treatment with MSM may lead to a better quality of life for migraine sufferers.
With 337 adults participating, the findings showed that those using migraine-specific medication (MSM), especially when pain was milder, reported the best outcomes. This included less daily disability and greater satisfaction with their medication.
Our results suggest that starting treatment with MSM may lead to a better quality of life for migraine sufferers.
References
- Tepper SJ, Ashina M, Reuter U, Hallström Y, Broessner G, et al. Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials. J Headache Pain. 2021;22:81. doi:10.1186/s10194-021-01292-w
- Seng EK, Robbins MS, Nicholson RA. Acute migraine medication adherence, migraine disability and patient satisfaction: A naturalistic daily diary study. Cephalalgia. 2017;37:955. doi:10.1177/0333102416663459
